• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促炎刺激对IDG-SW3骨细胞和人骨中FGF23表达的调控。

Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli.

作者信息

Ito Nobuaki, Wijenayaka Asiri R, Prideaux Matthew, Kogawa Masakazu, Ormsby Renee T, Evdokiou Andreas, Bonewald Lynda F, Findlay David M, Atkins Gerald J

机构信息

Bone Cell Biology Group, Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, SA 5005, Australia.

Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute, The University of Adelaide, Woodville, SA 5011, Australia.

出版信息

Mol Cell Endocrinol. 2015 Jan 5;399:208-18. doi: 10.1016/j.mce.2014.10.007. Epub 2014 Oct 16.

DOI:10.1016/j.mce.2014.10.007
PMID:25458698
Abstract

Fibroblast growth factor-23 (FGF23), produced by osteocytes, is the key physiological regulator of phosphate homeostasis. Sepsis patients often experience transient hypophosphataemia, suggesting the regulation of FGF23 levels by pro-inflammatory factors. Here, we used the osteocyte-like cell line IDG-SW3 to investigate the effect of pro-inflammatory stimuli on FGF23 production. In differentiated IDG-SW3 cultures, basal Fgf23 mRNA was dose-dependently up-regulated by pro-inflammatory cytokines TNF, IL-1β and TWEAK, and bacterial LPS. Similar effects were observed in human bone samples. TNF- and IL-1β-induced Fgf23 expression was NF-κB-dependent. Conversely, mRNA encoding negative regulators of FGF23, Phex, Dmp1 and Enpp1, were suppressed by TNF, IL-1β, TWEAK and LPS, independent of NF-κβ signalling. Galnt3, the protein product of which protects intact FGF23 protein from furin/furin-like proprotein convertase cleavage, increased in response to these treatments. C-terminal FGF23 and intact FGF23 protein levels also increased, the latter only in the presence of Furin inhibitors, suggesting that enzymatic cleavage exerts critical control of active FGF23 secretion by osteocytes. Our results demonstrate in principle that pro-inflammatory stimuli are capable of increasing osteocyte secretion of FGF23, which may contribute to hypophosphataemia during sepsis and possibly other inflammatory conditions.

摘要

成骨细胞产生的成纤维细胞生长因子23(FGF23)是磷稳态的关键生理调节因子。脓毒症患者常出现短暂性低磷血症,提示促炎因子对FGF23水平有调节作用。在此,我们使用类成骨细胞系IDG-SW3来研究促炎刺激对FGF23产生的影响。在分化的IDG-SW3培养物中,促炎细胞因子TNF、IL-1β和TWEAK以及细菌脂多糖(LPS)可使基础Fgf23 mRNA呈剂量依赖性上调。在人类骨样本中也观察到了类似的效应。TNF和IL-1β诱导的Fgf23表达依赖于NF-κB。相反,编码FGF23负调节因子Phex、Dmp1和Enpp1的mRNA被TNF、IL-1β、TWEAK和LPS抑制,且与NF-κβ信号传导无关。Galnt3的蛋白产物可保护完整的FGF23蛋白不被弗林蛋白酶/类弗林蛋白酶前蛋白转化酶切割,其表达在这些处理后增加。C末端FGF23和完整FGF23蛋白水平也增加,后者仅在存在弗林蛋白酶抑制剂的情况下增加,这表明酶切对成骨细胞分泌活性FGF23起着关键控制作用。我们的结果原则上证明,促炎刺激能够增加成骨细胞分泌FGF23,这可能导致脓毒症及其他可能的炎症状态下的低磷血症。

相似文献

1
Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli.促炎刺激对IDG-SW3骨细胞和人骨中FGF23表达的调控。
Mol Cell Endocrinol. 2015 Jan 5;399:208-18. doi: 10.1016/j.mce.2014.10.007. Epub 2014 Oct 16.
2
Sclerostin Directly Stimulates Osteocyte Synthesis of Fibroblast Growth Factor-23.骨硬化蛋白直接刺激骨细胞合成成纤维细胞生长因子 23。
Calcif Tissue Int. 2021 Jul;109(1):66-76. doi: 10.1007/s00223-021-00823-6. Epub 2021 Feb 22.
3
Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.成骨细胞向骨细胞转变过程中骨细胞内FGF23的翻译后加工
Bone. 2016 Mar;84:120-130. doi: 10.1016/j.bone.2015.12.055. Epub 2015 Dec 31.
4
Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.骨蛋白 PHEX 和 DMP1 通过涉及成纤维细胞生长因子受体 (FGFR) 信号通路的共同途径调节骨细胞中成纤维细胞生长因子 Fgf23 的表达。
FASEB J. 2011 Aug;25(8):2551-62. doi: 10.1096/fj.10-177816. Epub 2011 Apr 20.
5
Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells.细胞外磷酸盐调节 1α,25-二羟维生素 D3(1,25D)对骨细胞样细胞的作用。
J Steroid Biochem Mol Biol. 2013 Jul;136:183-6. doi: 10.1016/j.jsbmb.2012.09.029. Epub 2012 Oct 9.
6
p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.p38MAPK 调控 UMR106-成骨样细胞和 IDG-SW3 破骨细胞中成纤维细胞生长因子 23(FGF23)的合成。
J Endocrinol Invest. 2019 Dec;42(12):1477-1483. doi: 10.1007/s40618-019-01073-y. Epub 2019 Jun 14.
7
Osteocyte deficiency in hip fractures.髋关节骨折中的骨细胞缺乏。
Calcif Tissue Int. 2011 Oct;89(4):327-34. doi: 10.1007/s00223-011-9522-0. Epub 2011 Aug 28.
8
Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo.IDG-SW3 细胞系在体外复制成骨细胞向晚期成骨细胞分化,并在体内加速骨形成。
J Bone Miner Res. 2011 Nov;26(11):2634-46. doi: 10.1002/jbmr.465.
9
PHEX, FGF23, DMP1 and beyond.磷酸盐调节基因同源物(PHEX)、成纤维细胞生长因子23(FGF23)、牙本质基质蛋白1(DMP1)及其他相关因子
Curr Opin Nephrol Hypertens. 2008 Jul;17(4):357-62. doi: 10.1097/MNH.0b013e3282fd6e5b.
10
Bone as a source of FGF23: regulation by phosphate?骨骼作为成纤维细胞生长因子23(FGF23)的来源:受磷酸盐调节?
Bone. 2004 Nov;35(5):1192-9. doi: 10.1016/j.bone.2004.06.014.

引用本文的文献

1
A bidirectional mendelian-randomization analyses of genetically predicted circulating levels of systemic inflammatory regulators with risk of sepsis.对基因预测的全身炎症调节因子循环水平与败血症风险进行双向孟德尔随机化分析。
Medicine (Baltimore). 2025 Apr 25;104(17):e42199. doi: 10.1097/MD.0000000000042199.
2
FGF-23 as a Biomarker for Carotid Plaque Vulnerability: A Systematic Review.成纤维细胞生长因子23作为颈动脉斑块易损性的生物标志物:一项系统评价
Med Sci (Basel). 2025 Mar 10;13(1):27. doi: 10.3390/medsci13010027.
3
Excess fibroblast growth factor 23 in alcoholic osteomalacia is derived from the bone.
酒精性骨软化症中过量的成纤维细胞生长因子23来源于骨骼。
JBMR Plus. 2025 Jan 16;9(3):ziaf010. doi: 10.1093/jbmrpl/ziaf010. eCollection 2025 Mar.
4
Apical periodontitis microbiome association with salivary and serum inflammatory burden.根尖周炎微生物群与唾液和血清炎症负荷的关联
Int Endod J. 2025 Mar;58(3):504-515. doi: 10.1111/iej.14184. Epub 2025 Jan 4.
5
Low Bone Turnover, Mineralization Impairment, and Cortical Alterations in Patients with Axial Spondyloarthritis: A Histomorphometric Study.轴性脊柱关节炎患者的低骨转换、矿化障碍及皮质改变:一项组织形态计量学研究
Calcif Tissue Int. 2025 Jan 3;116(1):17. doi: 10.1007/s00223-024-01314-0.
6
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors.肾病患者的贫血与矿物质骨代谢紊乱:成纤维细胞生长因子-23及其他相关因素的作用
Int J Mol Sci. 2024 Nov 29;25(23):12838. doi: 10.3390/ijms252312838.
7
Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice.靶向敲除成纤维细胞生长因子 23 可挽救饮食诱导肥胖雌性小鼠的代谢紊乱。
Endocrinology. 2024 Oct 30;165(12). doi: 10.1210/endocr/bqae141.
8
Fibroblast growth factor 23 inhibition attenuates steroid-induced osteonecrosis of the femoral head through pyroptosis.成纤维细胞生长因子 23 抑制通过细胞焦亡减轻类固醇诱导的股骨头坏死。
Sci Rep. 2024 Jul 15;14(1):16270. doi: 10.1038/s41598-024-66799-z.
9
FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation Analysis.成纤维细胞生长因子-23、左心室肥厚与慢性肾脏病患者的死亡率:基于中介分析的再探讨
JACC Adv. 2023 Dec 9;3(1):100747. doi: 10.1016/j.jacadv.2023.100747. eCollection 2024 Jan.
10
FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.成纤维细胞生长因子 23 作为慢性肾脏病相关外周动脉疾病的潜在病理生理因素。
Int J Mol Sci. 2024 May 17;25(10):5457. doi: 10.3390/ijms25105457.